The Gene Panel Market is expanding as demand rises for targeted genetic analysis across oncology, hereditary disease testing, and personalized healthcare. MRFR estimates the global market at USD 3.56 billion in 2025, with revenue projected to reach USD 14.03 billion by 2035 at a 14.58% CAGR.
Modern gene panels can analyze multiple genetic targets within a single workflow, helping laboratories obtain broader genetic information efficiently. Advances in next-generation sequencing, automation, and bioinformatics are improving testing speed, coverage, and overall laboratory workflows.
Cancer risk assessment remains a leading application, while rare disease diagnosis and pharmacogenetics are creating additional demand. Hospitals, clinics, and diagnostic laboratories are increasingly adopting gene panel testing as genomic medicine becomes more integrated into clinical care.
North America accounted for 38.95% of market revenue in 2025, while Asia-Pacific is projected to grow at a 15.25% CAGR through 2035. Government-backed genomics programs and expanding laboratory infrastructure are supporting adoption across countries including China, India, and Japan.
Emerging opportunities include newborn screening, pharmacogenomic prescribing, population genomics, and liquid biopsy applications. As AI-assisted variant interpretation and digital reporting tools continue to develop, gene panels could become increasingly connected with broader precision-medicine platforms.
Explore additional reports to understand evolving market landscapes:
China Refurbished Medical Devices Market Outlook
Italy Life Science Tools Market Analysis
Italy Remote Patient Monitoring Market Distribution
